Trials / Completed
CompletedNCT04602611
Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers
A Randomized, Controlled Prospective Trial Evaluating The Impact Of A Nurse Navigation Program on Patients With Gastrointestinal Cancers Undergoing Oncological Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 228 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn about the impact of the Oncology Nurse Navigation program on the frequency of Emergency Department, urgent care visits and inpatient hospital admissions; and overall survival rate at 6 months. The investigators aim to understand if prompt and effective coordination of care provided by Oncology Nurse Navigation (ONN) service will reduce the number of avoidable, unplanned ED visits and hospitalizations, as well as adding measurable value to cancer care, and improve patient overall survival.
Detailed description
A randomized controlled prospective trial evaluating the effectiveness of a nurse navigation program for gastrointestinal cancer patients undergoing oncological treatment. Upon accrual, patients will be randomized 1:1 to receive standard of care plus ONN service (n = 107) or standard of care only (without ONN service; n = 107). Patients in both arms will be assessed for acute care utilization and overall survival (OS) rate at 6 months. Anticipated accrual period will be 30 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oncology Nurse Navigation | Providing the subject with the service of navigation (ONN) performed under LCI Patient Navigation Program (LPNP), led by a registered oncology nurse. |
Timeline
- Start date
- 2020-11-03
- Primary completion
- 2023-08-10
- Completion
- 2023-08-10
- First posted
- 2020-10-26
- Last updated
- 2025-01-30
- Results posted
- 2025-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04602611. Inclusion in this directory is not an endorsement.